Corteva
CTVA

Corteva (CTVA) analyst forecast and price target

Analyst forecast

Buy

Consensus of 23 analyst ratings

Buy
18
Hold
5
Sell
0
Average price target
$69.11+415.75% vs. last price
Last $13.40
Low $15.00High $103.00

Based on 9 analyst targets

Recent analyst ratings

FirmActionRatingPrice targetDate
UBSMaintainedNeutral$15.00 from $90.00Oct 12, 2026
KeybancUpgradedSector Weight → Overweight$17.00Oct 7, 2026
JP MorganUpgradedNeutral → Overweight$19.00 from $83.00Oct 6, 2026
Argus ResearchMaintainedBuy$91.00Sep 18, 2026
CitigroupMaintainedNeutral$91.00 from $86.00Sep 17, 2026
RBC CapitalMaintainedOutperform$103.00Sep 16, 2026
UBSMaintainedNeutral$90.00 from $85.00Sep 16, 2026
BMO CapitalMaintainedOutperform$95.00 from $100.00Sep 16, 2026
KeybancInitiated CoverageSector Weight—Sep 11, 2026
UBSMaintainedNeutral$85.00 from $89.00Aug 18, 2026
BMO CapitalMaintainedOutperform$100.00 from $95.00Aug 3, 2026
JP MorganMaintainedNeutral$83.00 from $77.00Aug 3, 2026
CitigroupMaintainedNeutral$86.00 from $85.00Aug 3, 2026
UBSMaintainedNeutral$89.00 from $86.00Aug 3, 2026
OppenheimerMaintainedOutperform$95.00 from $89.00Jul 23, 2026
RBC CapitalMaintainedOutperform$103.00 from $97.00Jul 21, 2026
B of A SecuritiesMaintainedBuy$96.00 from $90.00Jul 20, 2026
MizuhoMaintainedOutperform$97.00 from $96.00Jul 14, 2026
MizuhoMaintainedOutperform$96.00 from $94.00Jul 2, 2026
BarclaysMaintainedOverweight$91.00 from $84.00Jun 11, 2026

Frequently asked questions

  • What is the price target for CTVA stock?

    The average 12-month analyst price target for Corteva (CTVA) is $69.11, with a high estimate of $103.00 and a low of $15.00, across 9 analysts.

  • Is CTVA a buy, sell, or hold?

    Analysts covering Corteva currently average a Buy rating: 18 buy, 5 hold and 0 sell, from 23 analysts. Ratings reflect analyst opinion, not investment advice.

  • What upside do analysts see for CTVA?

    The average price target of $69.11 implies 415.75% upside from the last price of $13.40.

  • What is the latest analyst rating on CTVA?

    On Oct 12, 2026, UBS maintained Corteva at Neutral with a price target of $15.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.